Literature DB >> 7587188

Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.

D F Archer1, C K Mauck, A Viniegra-Sibal, F D Anderson.   

Abstract

Lea's Shield is a new vaginal barrier contraceptive that may offer advantages over existing methods. It is made of silicone which is resistant to petroleum-based lubricants, does not absorb odors, and does not cause allergic reactions in users with latex sensitivity. It has an anterior loop for ease of insertion and removal and a one-way flutter valve. Its novel design has sufficient volume to fill the posterior fornix, which helps keep it in place and prevent sperm from entering the cervical os. This study evaluated with a standard postcoital test (PCT) the ability of the Lea's Shield used with spermicide or non-spermicidal lubricant to prevent sperm from entering midcycle cervical mucus. Ten sterilized women underwent four PCT cycles: one cycle in which no contraceptive barrier was used (a baseline cycle) and 3 cycles in which one of the following was used: Lea's Shield with spermicide, or with non-spermicidal lubricant, or the contraceptive diaphragm used with spermicide. All volunteers demonstrated more than 5 progressively motile sperm per high power field in the cervical mucus after intercourse in the baseline cycle. No motile sperm were found in the cervical mucus in any cycle in which Lea's Shield or the diaphragm was used with spermicide. No motile sperm were found in cervical mucus in 9 of 10 cycles in which Lea's Shield was used without spermicide. Only two progressively motile sperm were present in the cervical mucus of one volunteer who used the shield with non-spermicidal lubricant.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Americas; Barrier Methods; Biology; Clinical Research; Contraception; Contraception Research; Contraceptive Methods; Developed Countries; Family Planning; Genitalia; Germ Cells; North America; Northern America; Physiology; Research Methodology; Research Report; Spermatozoa; United States; Urogenital System; Vaginal Barrier Methods; Vaginal Diaphragm; Vaginal Spermicides

Mesh:

Substances:

Year:  1995        PMID: 7587188     DOI: 10.1016/0010-7824(95)00162-4

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception.

Authors:  Bhawana Shrestha; Alison Schaefer; Yong Zhu; Jamal Saada; Timothy M Jacobs; Elizabeth C Chavez; Stuart S Olmsted; Carlos A Cruz-Teran; Gabriela Baldeon Vaca; Kathleen Vincent; Thomas R Moench; Samuel K Lai
Journal:  Sci Transl Med       Date:  2021-08-11       Impact factor: 17.956

2.  Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception.

Authors:  Bhawana Shrestha; Kathleen Vincent; Alison Schaefer; Yong Zhu; Gracie Vargas; Massoud Motamedi; Kelsi Swope; Josh Morton; Carrie Simpson; Henry Pham; Miles B Brennan; Michael H Pauly; Larry Zeitlin; Barry Bratcher; Kevin J Whaley; Thomas R Moench; Samuel K Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

3.  The postcoital test in the development of new vaginal contraceptives†.

Authors:  Christine K Mauck; Kathleen L Vincent
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.